PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26121139-0	2015	Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.	Propafenone	105-118	ryanodine receptor 2, cardiac	Mus musculus	49-53	
26121139-2	2015	We hypothesized that differences in RyR2 activity induced by CPVT mutations determines the potency of open-state RyR2 blockers like flecainide (FLEC) and R-propafenone (RPROP) against Ca2+ waves in cardiomyocytes.	Propafenone	154-167	ryanodine receptor 2, cardiac	Mus musculus	36-40	
26121139-2	2015	We hypothesized that differences in RyR2 activity induced by CPVT mutations determines the potency of open-state RyR2 blockers like flecainide (FLEC) and R-propafenone (RPROP) against Ca2+ waves in cardiomyocytes.	Propafenone	154-167	ryanodine receptor 2, cardiac	Mus musculus	113-117	
26121139-2	2015	We hypothesized that differences in RyR2 activity induced by CPVT mutations determines the potency of open-state RyR2 blockers like flecainide (FLEC) and R-propafenone (RPROP) against Ca2+ waves in cardiomyocytes.	Propafenone	169-174	ryanodine receptor 2, cardiac	Mus musculus	36-40	
26121139-2	2015	We hypothesized that differences in RyR2 activity induced by CPVT mutations determines the potency of open-state RyR2 blockers like flecainide (FLEC) and R-propafenone (RPROP) against Ca2+ waves in cardiomyocytes.	Propafenone	169-174	ryanodine receptor 2, cardiac	Mus musculus	113-117